390 related articles for article (PubMed ID: 17318448)
21. Expression profile of copper transporters in sensitive and cisplatin/oxaliplatin-resistant tumor cell lines.
Kassack MU; Stratenschulte C
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):597-8. PubMed ID: 16372532
[No Abstract] [Full Text] [Related]
22. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
[TBL] [Abstract][Full Text] [Related]
23. Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer.
Li T; Peng J; Zeng F; Zhang K; Liu J; Li X; Ouyang Q; Wang G; Wang L; Liu Z; Liu Y
Int J Clin Pharmacol Ther; 2017 Oct; 55(10):774-780. PubMed ID: 28737129
[TBL] [Abstract][Full Text] [Related]
24. Platination of the copper transporter ATP7A involved in anticancer drug resistance.
Calandrini V; Arnesano F; Galliani A; Nguyen TH; Ippoliti E; Carloni P; Natile G
Dalton Trans; 2014 Aug; 43(31):12085-94. PubMed ID: 24983998
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
[TBL] [Abstract][Full Text] [Related]
26. Role of copper transporters in the uptake and efflux of platinum containing drugs.
Safaei R
Cancer Lett; 2006 Mar; 234(1):34-9. PubMed ID: 16297532
[TBL] [Abstract][Full Text] [Related]
27. Human copper transporters: mechanism, role in human diseases and therapeutic potential.
Gupta A; Lutsenko S
Future Med Chem; 2009 Sep; 1(6):1125-42. PubMed ID: 20454597
[TBL] [Abstract][Full Text] [Related]
28. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
[TBL] [Abstract][Full Text] [Related]
29. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.
Wu Z; Liu Q; Liang X; Yang X; Wang N; Wang X; Sun H; Lu Y; Guo Z
J Biol Inorg Chem; 2009 Nov; 14(8):1313-23. PubMed ID: 19669174
[TBL] [Abstract][Full Text] [Related]
30. Monitoring Interactions Inside Cells by Advanced Spectroscopies: Overview of Copper Transporters and Cisplatin.
Lasorsa A; Natile G; Rosato A; Tadini-Buoninsegni F; Arnesano F
Curr Med Chem; 2018 Feb; 25(4):462-477. PubMed ID: 29121854
[TBL] [Abstract][Full Text] [Related]
31. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.
Nakayama K; Kanzaki A; Ogawa K; Miyazaki K; Neamati N; Takebayashi Y
Int J Cancer; 2002 Oct; 101(5):488-95. PubMed ID: 12216079
[TBL] [Abstract][Full Text] [Related]
32. Interference between copper transport systems and platinum drugs.
Arnesano F; Natile G
Semin Cancer Biol; 2021 Nov; 76():173-188. PubMed ID: 34058339
[TBL] [Abstract][Full Text] [Related]
33. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC).
Li ZH; Qiu MZ; Zeng ZL; Luo HY; Wu WJ; Wang F; Wang ZQ; Zhang DS; Li YH; Xu RH
J Transl Med; 2012 Feb; 10():21. PubMed ID: 22304828
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
[TBL] [Abstract][Full Text] [Related]
35. Overcoming platinum drug resistance with copper-lowering agents.
Chen HH; Kuo MT
Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
[TBL] [Abstract][Full Text] [Related]
36. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells.
Katano K; Safaei R; Samimi G; Holzer A; Rochdi M; Howell SB
Mol Pharmacol; 2003 Aug; 64(2):466-73. PubMed ID: 12869652
[TBL] [Abstract][Full Text] [Related]
37. [Structure and function of ATP7A and ATP7B proteins--Cu-transporting ATPases].
Lenartowicz M; Krzeptowski W
Postepy Biochem; 2010; 56(3):317-27. PubMed ID: 21117320
[TBL] [Abstract][Full Text] [Related]
38. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.
Katano K; Kondo A; Safaei R; Holzer A; Samimi G; Mishima M; Kuo YM; Rochdi M; Howell SB
Cancer Res; 2002 Nov; 62(22):6559-65. PubMed ID: 12438251
[TBL] [Abstract][Full Text] [Related]
39. Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.
Liu JJ; Lu J; McKeage MJ
Curr Cancer Drug Targets; 2012 Oct; 12(8):962-86. PubMed ID: 22794121
[TBL] [Abstract][Full Text] [Related]
40. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.
Chen HH; Yan JJ; Chen WC; Kuo MT; Lai YH; Lai WW; Liu HS; Su WC
Lung Cancer; 2012 Feb; 75(2):228-34. PubMed ID: 21788094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
